Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under Vitamin K antagonists

1. Ríos, S.J.
2. Rivera-Caravaca, J.M.
3. Aroca-Valverde, C.
4. Reguilón-Gallego, L.
5. Castillo-Rodríguez, M.
6. Esteve-Pastor, M.A.
7. Vicente, V.
8. Marín, F.
9. Roldán, V.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/QJMED/HCY250 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus